An Overview of Diagnosis and Treatment of Melasma

Ramadan S. Hussein, Walid Kamal Abdelbasset

International Journal of Biomedicine. 2022;12(2):199-203.
DOI: 10.21103/Article12(2)_RA5
Originally published June 5, 2022


Melasma is a persistent hyperpigmentation condition that is most commonly seen in middle-aged women. The malar, central, and mandibular parts of the face are most affected by this condition, Factors that contribute to melasma's etiology are still a mystery. Multifactorial causes are now widely accepted in these cases. In order to diagnose melasma and its variants, distinguish them from other pigmented illnesses, and keep track of treatment progress and side effects, several diagnostic tools are employed. The limited response and high recurrence rate make treating melasma difficult. Melasma can be treated with a variety of methods, including topical medicines, laser treatment, and injections. The objective of this article is to offer a concise overview of melasma diagnosis and management.

hyperpigmentation • melasma • diagnosis • dermoscopy • treatment
  1. Rigopoulos D, Gregoriou S, Katsambas A. Hyperpigmentation and melasma. J Cosmet Dermatol. 2007 Sep;6(3):195-202. doi: 10.1111/j.1473-2165.2007.00321.x. 
  2. Pérez-Bernal A, Muñoz-Pérez MA, Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol. 2000 Sep-Oct;1(5):261-8. doi: 10.2165/00128071-200001050-00001. 
  3. Khanna N, Rasool S. Facial melanoses: Indian perspective. Indian J Dermatol Venereol Leprol. 2011 Sep-Oct;77(5):552-63; quiz 564. doi: 10.4103/0378-6323.84046.
  4. Lynde CB, Kraft JN, Lynde CW. Topical treatments for melasma and postinflammatory hyperpigmentation. Skin Therapy Lett. 2006 Nov;11(9):1-6. 
  5. Rendon MI, Gaviria JI. Review of skin-lightening agents. Dermatol Surg. 2005 Jul;31(7 Pt 2):886-9; discussion 889. doi: 10.1111/j.1524-4725.2005.31736. 
  6. Callender VD, St Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol. 2011 Apr 1;12(2):87-99. doi: 10.2165/11536930-000000000-00000. 
  7. Anstey AV. Disorders of skin colour. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Rook/Wilkinson/Ebling: Textbook of Dermatology, 8th edn. Blackwell Scientific Publications, Oxford, 2010: 58.1–58.59.
  8. Stulberg DL, Clark N, Tovey D. Common hyperpigmentation disorders in adults: Part I. Diagnostic approach, café au lait macules, diffuse hyperpigmentation, sun exposure, and phototoxic reactions. Am Fam Physician. 2003 Nov 15;68(10):1955-60. 
  9. Bishop JA. Lentigos, Melanocytic Naevi and Melanoma. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Rook/ Wilkinson/Ebling: Textbook of Dermatology, 8th edn. Blackwell Scientific Publications, Oxford, 2010: 54.1–58.57.
  10. Stratigos AJ, Katsambas AD. Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients. Am J Clin Dermatol. 2004;5(3):161-8. doi: 10.2165/00128071-200405030-00004. 
  11. Abdel-Naser MB, Verma SB, Abdallah MA. Common dermatoses in moderately pigmented skin: uncommon presentations. Clin Dermatol. 2005 Sep-Oct;23(5):446-56. doi: 10.1016/j.clindermatol.2005.01.020. 
  12. Stolz W, Braun-Falco O, Bilek P, et al. Color Atlas of Dermatoscopy. Boston: Blackwell Scientific Publications, 1994.
  13. Binder M, Schwarz M, Winkler A, Steiner A, Kaider A, Wolff K, Pehamberger H. Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol. 1995 Mar;131(3):286-91. doi: 10.1001/archderm.131.3.286. 
  14. Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Sammarco E, Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol. 1998 Dec;134(12):1563-70. doi: 10.1001/archderm.134.12.1563.
  15. Binder M, Kittler H, Seeber A, Steiner A, Pehamberger H, Wolff K. Epiluminescence microscopy-based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Res. 1998 Jun;8(3):261-6. doi: 10.1097/00008390-199806000-00009. 
  16. Handog EB, Enriquez-Macarayo MJ. Melasma and Vitiligo in Brown Skin. New Delhi, India: Springer; 2017.
  17. Tamler C, Fonseca RMR, Pereira FBC, Barcaui CB. Classification of melasma by dermoscopy: comparative study with Wood's lamp. Surg Cosme Dermatol. 2009;1(3):115-119.
  18. Khanna N, Rasool S. Facial melanoses: Indian perspective. Indian J Dermatol Venereol Leprol. 2011 Sep-Oct;77(5):552-63; quiz 564. doi: 10.4103/0378-6323.84046
  19. Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC Jr. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981 Jun;4(6):698-710. doi: 10.1016/s0190-9622(81)70071-9. 
  20. Grimes PE, Yamada N, Bhawan J. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol. 2005 Apr;27(2):96-101. doi: 10.1097/ 
  21. Taylor S, Grimes P, Lim J, Im S, Lui H. Postinflammatory hyperpigmentation. J Cutan Med Surg. 2009 Jul-Aug;13(4):183-91. doi: 10.2310/7750.2009.08077. 
  22. Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011 Oct;65(4):689-697. doi: 10.1016/j.jaad.2010.12.046. 
  23. Hunter J Savin J, Dahl M. Disorders of pigmentation. In Hunter J Savin J, Dahl M eds. Clinical Dermatology, 3edn. Blackwell Scientific Publications, Oxford, 2002: 242–252.
  24. Mahmoud BH, Hexsel CL, Hamzavi IH, Lim HW. Effects of visible light on the skin. Photochem Photobiol. 2008 Mar-Apr;84(2):450-62. doi: 10.1111/j.1751-1097.2007.00286.x.
  25. Erbil H, Sezer E, Taştan B, Arca E, Kurumlu Z. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. J Dermatol. 2007 Jan;34(1):25-30. doi: 10.1111/j.1346-8138.2007.00211.x. 
  26. Dogra S, Kanwar AJ, Parsad D. Adapalene in the treatment of melasma: a preliminary report. J Dermatol. 2002 Aug;29(8):539-40. doi: 10.1111/j.1346-8138.2002.tb00324.x.
  27. Nikolaou V, Stratigos AJ, Katsambas AD. Established treatments of skin hypermelanoses. J Cosmet Dermatol. 2006 Dec;5(4):303-8. doi: 10.1111/j.1473-2165.2006.00276.x. 
  28. Nouri K, Bowes L, Chartier T, Romagosa R, Spencer J. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol Surg. 1999 Jun;25(6):494-7. doi: 10.1046/j.1524-4725.1999.08248.x.
  29. Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, Park YM. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg. 2006 May;32(5):626-31. doi: 10.1111/j.1524-4725.2006.32133.x. 
  30. Wang CC, Hui CY, Sue YM, Wong WR, Hong HS. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg. 2004 Sep;30(9):1196-200. doi: 10.1111/j.1524-4725.2004.30371.x. 

Download Article
Received April 19, 2022.
Accepted May 24, 2022.
©2022 International Medical Research and Development Corporation.